Myriad launches hereditary cancer detection tool
07 September 2017 | News
riskScore is an algorithm designed to combine genetic markers with a patient’s family and clinical history.
Courtesy- Shuttershock
US-based molecular diagnostics firm Myriad Genetics has introduced a new medical tool, riskScore, to support its myRisk test developed for hereditary cancer.
riskScore is an algorithm designed to combine genetic markers with a patient’s family and clinical history to quantify the risk of breast cancer development.
No hay comentarios:
Publicar un comentario